At EVOQ Remedies, they have a vision to be the leading pharmaceutical and consumer products across the Globe all the way through concentrated Research and Development. To attain Global excellence in Healthcare and providing the highest quality products and services.
Their vision is to be established as the best pharmaceutical company, in terms of expertise, innovation and responsible entrepreneurship, while returning value to our stakeholders.
Mr. Bhumishth Narendrabhai Patel and Mrs. Payal Bhumishth Patel are the company promoters.
| Particulars | 31-Mar-21 | 31-Mar-20 | 31-Mar-19 |
|---|---|---|---|
| Total Assets (In ₹ Millions) | 804.63 | 565.22 | 214.78 |
| Total Revenue (In ₹ Millions) | 1002.48 | 907.21 | 325 |
| Profit After Tax (PAT) (In ₹ Millions) | 71.38 | 0.03 | 1.11 |
| Date | GMP | Kostak | Subject to Sauda |
|---|
| Date & Time | QIB | NII | RII | Total |
|---|---|---|---|---|
| Day 1 - 17 Mar 2022 | ||||
| Day 2 - 21 Mar 2022 | ||||
| Day 3 - 22 Mar 2022 |
Please click the link below to check the IPO allotment status.
IPO Allotment StatusEvoq Remedies Limited IPO will open on 17 Mar 2022 and close on 22 Mar 2022.
Evoq Remedies Limited IPO will list on .
The offer price of Evoq Remedies Limited IPO is ₹27.
The lot size of Evoq Remedies Limited IPO is 4000.
The Grey Market Premium (GMP) price of Evoq Remedies Limited IPO is Not Available at the moment.
The Kostak price of Evoq Remedies Limited IPO is Not Available at the moment.
The Subject to Sauda price for Evoq Remedies Limited IPO is Not Available at the moment.
Please Leave Your Message
Evoq Remedies Limited IPO Review/Comments